review Open AccessTop 1% cited
Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
Alimentary Pharmacology & Therapeutics · 2001 · Vol. 15(3) · pp. 355–361
Thierry Poynard✉(Sorbonne Université)Corinne Regimbeau(Sorbonne Université)Y. Benhamou(Sorbonne Université)
Abstract
According to this overview five drugs have proved their clinical efficacy in patients with irritable bowel syndrome, without significant adverse reactions: cimetropium bromide, pinaverium bromide, trimebutine, octilium bromide and mebeverine.
Gastrointestinal motility and disordersPathogenesis and Treatment of HiccupsComplementary and Alternative Medicine StudiesMedicinePlaceboIrritable bowel syndromeOdds ratioInternal medicineClinical trialRandomized controlled trialAdverse effectAnesthesiaGastroenterology
MeSH terms
AdultColonic Diseases, FunctionalFemaleHumansMaleMiddle AgedParasympatholyticsPlacebosAbdominal PainOdds RatioTreatment Outcome
Citations
405
FWCI
24.08
field-weighted impact
References
61
Percentile
100%
vs. same field & year
Citations per year
Cited by
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
World Journal of Gastroenterology · 2014 · 482 citations
AGA technical review on irritable bowel syndrome
Gastroenterology · 2002 · 1,401 citations
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
Gastroenterology · 2005 · 1,423 citations
References
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT<sub>3</sub> receptor antagonist
Alimentary Pharmacology & Therapeutics · 1999 · 372 citations
Methods for combining randomized clinical trials: Strengths and limitations
Statistics in Medicine · 1987 · 1,047 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.